Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Evaluator-blinded, Parallel Group, no Treatment Controlled, Multi-center Study to Evaluate Effectiveness and Safety of GP0109 for Augmentation and Correction of Retrusion in the Chin Region

NCT04631263 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT04631263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04631263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Evaluator-blinded, Parallel Group, no Treatment Controlled, Multi-center Study to Evaluate Effectiveness and Safety of GP0109 for Augmentation and Correction of Retrusion in the Chin Region
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Completed
Start date
January 29, 2021
Completion date
June 16, 2022
Enrollment
140 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chin augmentation and correction